Literature DB >> 21870059

Resveratrol in the prevention and treatment of coronary artery disease.

Louis M Chu1, Antonio D Lassaletta, Michael P Robich, Frank W Sellke.   

Abstract

Resveratrol is a polyphenolic compound found in red wine that is believed to be responsible for its beneficial cardiovascular effects. Extensive research in the past several decades has identified multiple mechanisms by which resveratrol modifies the cardiovascular risk factors that lead to coronary artery disease, yet translation to the clinical arena has been unexpectedly slow. In this article, we review the existing evidence regarding the beneficial effects of resveratrol and briefly discuss its potential therapeutic applications.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21870059     DOI： 10.1007/s11883-011-0202-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  50 in total

1.  Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation.

Authors:  Eun Yong Chung; Byung Hak Kim; Jin-Tae Hong; Chong-Kil Lee; Byeongwoo Ahn; Sang-Yoon Nam; Sang-Bae Han; Youngsoo Kim
Journal:  J Nutr Biochem       Date:  2010-12-28       Impact factor: 6.048

2.  Death in the United States, 2007.

Authors:  Arialdi M Miniño; Jiaquan Xu; Kenneth D Kochanek; Betzaida Tejada-Vera
Journal:  NCHS Data Brief       Date:  2009-12

3.  Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin.

Authors:  Beata Olas; Barbara Wachowicz; Joanna Saluk-Juszczak; Tomasz Zieliński
Journal:  Thromb Res       Date:  2002-08-15       Impact factor: 3.944

Review 4.  Resveratrol in cardiovascular health and disease.

Authors:  Goran Petrovski; Narasimman Gurusamy; Dipak K Das
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

5.  Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro.

Authors:  Katharina Schroecksnadel; Christiana Winkler; Barbara Wirleitner; Harald Schennach; Günter Weiss; Dietmar Fuchs
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

6.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Authors:  Victoria A Brown; Ketan R Patel; Maria Viskaduraki; James A Crowell; Marjorie Perloff; Tristan D Booth; Grygoriy Vasilinin; Ananda Sen; Anna Maria Schinas; Gianfranca Piccirilli; Karen Brown; William P Steward; Andreas J Gescher; Dean E Brenner
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

7.  Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis.

Authors:  Oscar H Franco; Anna Peeters; Luc Bonneux; Chris de Laet
Journal:  Hypertension       Date:  2005-06-27       Impact factor: 10.190

Review 8.  Clinical trials of resveratrol.

Authors:  Ketan R Patel; Edwina Scott; Victoria A Brown; Andreas J Gescher; William P Steward; Karen Brown
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

9.  Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1.

Authors:  Dae Weon Park; Kheewoong Baek; Jae Ryong Kim; Jae Jin Lee; Sang Ho Ryu; Byung Rho Chin; Suk Hwan Baek
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

Review 10.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690
View more
  18 in total

1.  Cardioprotective effects of red wine and vodka in a model of endothelial dysfunction.

Authors:  Antonio D Lassaletta; Louis M Chu; Nassrene Y Elmadhun; Thomas A Burgess; Jun Feng; Michael P Robich; Frank W Sellke
Journal:  J Surg Res       Date:  2012-06-21       Impact factor: 2.192

2.  Does resveratrol improve insulin signaling in chronically ischemic myocardium?

Authors:  Ashraf A Sabe; Nassrene Y Elmadhun; Michael P Robich; Rahul S Dalal; Frank W Sellke
Journal:  J Surg Res       Date:  2013-03-29       Impact factor: 2.192

3.  Treating cardiovascular atherosclerotic plaques with Tongmaijiangzhi (TMJZ) capsule.

Authors:  Hong-Qiang Ren; Li Zhao; Zhong Shuang Zhang; Zhong Wang; Li Wang; Jun Cang Duan; Li Li; Zhi Hong Zhai; De Tao Qu; Hui Huang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

4.  SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.

Authors:  Ling Zuo; Reas S Khan; Vivian Lee; Kimberly Dine; Wen Wu; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

5.  Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.

Authors:  Ashraf A Sabe; Ahmed A Sadek; Nassrene Y Elmadhun; Rahul S Dalal; Michael P Robich; Cesario Bianchi; Frank W Sellke
Journal:  J Med Food       Date:  2015-01       Impact factor: 2.786

6.  Resveratrol regulates autophagy signaling in chronically ischemic myocardium.

Authors:  Ashraf A Sabe; Nassrene Y Elmadhun; Rahul S Dalal; Michael P Robich; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

7.  Ethanol promotes arteriogenesis and restores perfusion to chronically ischemic myocardium.

Authors:  Antonio D Lassaletta; Nassrene Y Elmadhun; Yuhong Liu; Jun Feng; Thomas A Burgess; Nicholas W Karlson; Roger J Laham; Frank W Sellke
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

8.  The Sirtuin System: The Holy Grail of Resveratrol?

Authors:  Dilbahar S Mohar; Shaista Malik
Journal:  J Clin Exp Cardiolog       Date:  2012-11

9.  Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice.

Authors:  Qiong Chen; Ermao Wang; Liping Ma; Pei Zhai
Journal:  Lipids Health Dis       Date:  2012-05-20       Impact factor: 3.876

Review 10.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.